Skip to main content

Gynecology

  • Chapter
Surgery
  • 780 Accesses

Abstract

Given the anatomical proximity of the female reproductive system to other abdominal and pelvic organs, Y common surgeons commonly find themselves faced with a decision regarding female reproductive organs. Likewise, the overlap of signs and symptoms in gynecological and surgical diseases commonly leads to the inclusion of a gynecological disease in a differential diagnosis.1 Thus, it is imperative that the surgeon has a general understanding of operative and non-operative gynecology.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Curtis KM, Hillis SD, Kieke BA Jr, Brett KM, Marchbanks PA, Peterson HB. Visits to emergency departments for gynecologic disorders in the United States, 1992–1994. Obstet Gynecol 1998; 91: 1007–1012.

    Article  Google Scholar 

  2. Visco AG, Del Priore G. Postmenopausal Bartholin gland enlargement: a hospital-based cancer risk asessment. Obstet Gynecol 1996; 87: 286–290.

    Article  PubMed  CAS  Google Scholar 

  3. Speroff L, Glass RH, Kase NG. Clinical Gynecologic Endocrinology and Infertility, 5th ed. Baltimore: Williams & Wilkins, 1994.

    Google Scholar 

  4. Center for Disease Control and Prevention. Chlamydia trachomatis genital infections-United States, 1995. MMWR (Morb Mortal Wkly Rep) 1997; 46: 193–198.

    Google Scholar 

  5. Lepine LA, Hillis SD, Marchbanks PA, Joesoef MR, Peterson HB, Westrom L. Severity of pelvic inflammatory disease as a predictor of the probability of live birth. Am J Obstet Gynecol 1998; 178: 977–981.

    Article  PubMed  CAS  Google Scholar 

  6. Centers for Disease Control and Prevention. 1998 guidelines for treatment of sexually transmitted diseases. MMWR (Morb Mortal Wkly Rep) 1998; 47 (RR-1): 1–111.

    Google Scholar 

  7. Farley TM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 1992; 339: 785–788.

    Article  PubMed  CAS  Google Scholar 

  8. Scholes D, Stergachis A, Ichikawa LE, Heidrich FE, Holmes KK, Stamm WE. Vaginal douching as a risk factor for cervical Chlamydia trachomatis infection. Obstet Gynecol 1998; 91: 993–997.

    Article  PubMed  CAS  Google Scholar 

  9. Jacobson L. Differential diagnosis of acute pelvic inflammatory disease. Am J Obstet Gynecol 1980; 138: 1006–1011.

    PubMed  CAS  Google Scholar 

  10. Patten RM, Vincent LM, Wolner-Hanssen P, Thorpe E Jr. Pelvic inflammatory disease. Endovaginal sonography with laparoscopie correlation. J Ultrasound Med 1990; 9: 681–689.

    PubMed  CAS  Google Scholar 

  11. Cacciatore B, Leminen A, Ingman-Friberg S, Ylostalo P, Paavonen J. Transvaginal sonographic findings in ambulatory patients with suspected pelvic inflammatory disease. Obstet Gynecol 1992; 80: 912–916.

    PubMed  CAS  Google Scholar 

  12. Boardman LA, Peipert JF, Brody JM, Cooper AS, Sung J. Endovaginal sonography for the diagnosis of upper genital tract infection. Obstet Gynecol 1997; 90: 54–57.

    Article  PubMed  CAS  Google Scholar 

  13. Perez-Medina T, Huertas MA, Bajo JM. Early ultrasound-guided transvaginal drainage of tubo-ovarian abscesses: a randomized study. Ultrasound Obstet Gynecol 1996; 7: 435–438.

    Article  PubMed  CAS  Google Scholar 

  14. Aboulghar MA, Mansour RT, Serour GI. Ultrasonographically guided transvaginal aspiration of tuboovarian abscesses and pyosalpinges: an optional treatment for acute pelvic inflammatory disease. Am J Obstet Gynecol 1995; 172: 1501–1503.

    Article  PubMed  CAS  Google Scholar 

  15. Nelson AL, Sinow RM, Renslo R, Renslo J, Atamdede F. Endovaginal ultrasonographically guided transvaginal drainage for treatment of pelvic abscesses. Am J Obstet Gynecol 1995; 172: 1926–1932.

    Article  PubMed  CAS  Google Scholar 

  16. Feld R, Eschelman DJ, Sagerman JE, Segal S, Hovsepian DM, Sullivan KL. Treatment of pelvic abscesses and other fluid collections: efficacy of transvaginal sonographically guided aspiration and drainage. AJR Am J Roentgenol 1994; 163: 1141–1145.

    Article  PubMed  CAS  Google Scholar 

  17. vanSonnenberg E, D’Agostino HB, Casola G, Goodacre BW, Sanchez RB, Taylor B. US-guided transvaginal drainage of pelvic abscesses and fluid collections. Radiology 1991; 181: 53–56.

    PubMed  CAS  Google Scholar 

  18. Breen JL. A 21 year survey of 654 ectopie pregnancies. Am J Ob-stet Gynecol 1970; 106: 1004–1019.

    CAS  Google Scholar 

  19. Centers for Disease Control and Prevention. Advanced report of final mortality statistics. Monthly Vital Statistics Report 1995; 43: 11–13.

    Google Scholar 

  20. Centers for Disease Control and Prevention. Ectopic pregnancy-United States 1988–1989. MMWR (Morb Mortal Wkly Rep) 1992; 41: 591–594.

    Google Scholar 

  21. Centers for Disease Control and Prevention. Ectopic pregnancy-United States 1990–1992. MMWR (Morb Mortal Wkly Rep) 1995; 44: 46–48.

    Google Scholar 

  22. Peterson HB, Xia Z, Hughes JM, Wilcox LS, Tylor LR, Trussell J. The risk of ectopie pregnancy after tubal sterilization. U.S. Collaborative Review of Sterilization Working Group. N Engl J Med 1997; 336: 762–767.

    Article  PubMed  CAS  Google Scholar 

  23. Kadar N, Bohrer M, Kemmann E, Shelden R. The discriminatory human chorionic gonadotropin zone for endovaginal sonography: a prospective, randomized study. Fertil Steril 1994; 61: 1016–1020.

    PubMed  CAS  Google Scholar 

  24. Barnhart K, Mennuti MT, Benjamin I, Jacobson S, Goodman D, Coutifaris C. Prompt diagnosis of ectopie pregnancy in an emergency department setting. Obstet Gynecol 1994; 84: 1010–1015.

    PubMed  CAS  Google Scholar 

  25. Kadar N, Caldwell BV, Romero R. A method of screening for ectopic pregnancy and its indications. Obstet Gynecol 1981; 58: 162–166.

    PubMed  CAS  Google Scholar 

  26. Murphy AA, Nager CW, Wujek JJ, Kettel LM, Torp VA, Chin HG. Operative laparoscopy versus lararotomy for the management of ectopie pregnancy: a prospective trial. Fertil Steril 1992; 57: 1180–1185.

    PubMed  CAS  Google Scholar 

  27. Vermesh M, Silva PD, Rosen GF, Stein AL, Fossum GT, Sauer MV. Management of unruptured ectopie gestation by linear salpingostomy: a prospective, randomized clinical trial of laparoscopy versus laparotomy. Obstet Gynecol 1989; 73: 400–404.

    PubMed  CAS  Google Scholar 

  28. Lundorff P, Thorburn J, Lindblom B. Fertility outcome after conservative surgical treatment of ectopic pregnancy evaluated in a randomized trial. Fertil Steril 1992; 57: 998–1002.

    PubMed  CAS  Google Scholar 

  29. Tulandi T, Guralnick M. Treatment of tubal ectopie pregnancy by salpingotomy with or without tubal suturing and salpingectomy. Fertil Steril 1991; 55: 53–55.

    PubMed  CAS  Google Scholar 

  30. Korell M, Albrich W, Hepp H. Fertility after organ-preserving surgery of ectopic pregnancy results of a multicenter study. Fertil Steril 1997; 68: 220–223.

    Article  PubMed  CAS  Google Scholar 

  31. Silva PD, Schaper AM, Rooney B. Reproductive outcome after 143 laparoscopie procedures for ectopic pregnancy Obstet Gynecol 1993; 81: 710–715.

    CAS  Google Scholar 

  32. de la Cruz A, Cumming DC. Factors determining fertility after conservative or radical surgical treatment for ectopic pregnancy. Fertil Steril 1997; 68: 871–874.

    Article  Google Scholar 

  33. Hajenius PJ, Engelsbel S, Mol BW, et al. Randomised trial of systemic methotrexate versus laparoscopic salpingostomy in tubal pregnancy Lancet 1997; 350: 774–779.

    CAS  Google Scholar 

  34. Stovall TG, Ling FW. Single-dose methotrexate: an expanded clinical trial. Am J Obstet Gynecol 1993; 168: 1759–1762.

    Article  PubMed  CAS  Google Scholar 

  35. Lipscomb GH, Bran D, McCord ML, Portera JC, Ling FW. Analysis of three hundred fifteen ectopic pregnancies treated with single-dose methotrexate. Am J Obstet Gynecol 1998; 178: 1354 1358.

    Google Scholar 

  36. Stika CS, Anderson L, Frederiksen MC. Single-dose methotrexate for the treatment of ectopic pregnancy: Northwestern Memorial Hospital three-year experience. Am J Obstet Gynecol 1996; 174: 1840–1846.

    Article  PubMed  CAS  Google Scholar 

  37. Glock JL, Johnson JV, Brumsted JR. Efficacy and safety of single-dose systemic methotrexate in the treatment of ectopic pregnancy. Fertil Steril 1994; 62: 716–721.

    PubMed  CAS  Google Scholar 

  38. Alexander JM, Rouse DJ, Varner E, Austin JM Jr. Treatment of the small unruptured ectopic pregnancy: a cost analysis of methotrexate versus laparoscopy. Obstet Gynecol 1996; 88: 123127.

    Google Scholar 

  39. Sommerville M, Grimes DA, Koonings PP, Campbell K. Ovarian neoplasms and the risk of adnexal torsion. Am J Obstet Gynecol 1991; 164: 577–578.

    Article  PubMed  CAS  Google Scholar 

  40. Merritt DF. Torsion of the uterine adnexa: a review. Adolesc Pediatr Gynecol 1991; 4: 3–13.

    Google Scholar 

  41. Chang KH, Hwang KJ, Kwon HC, et al. Conservative therapy of adnexal torsion employing color Doppler sonography. J Am Assoc Gynecol Laparosc 1998; 5: 13–17.

    Article  PubMed  CAS  Google Scholar 

  42. Lee EJ, Kwon HC, Joo HJ, Suh JH, Fleischer AC. Diagnosis of ovarian torsion with color Doppler sonography: depiction of twisted vascular pedicle. J Ultrasound Med 1998; 17: 83–89.

    PubMed  CAS  Google Scholar 

  43. Fleischer AC, Stein SM, Cullinan JA, Warner MA. Color Doppler sonography of adnexal torsion. J Ultrasound Med 1995; 14: 523–528.

    PubMed  CAS  Google Scholar 

  44. Zweizig S, Perron J, Grubb D, Mishell DR Jr. Conservative management of adnexal torsion. Am J Obstet Gynecol 1993; 168: 1791–1795.

    Article  PubMed  CAS  Google Scholar 

  45. Chapron C, Capella-Allouc S, Dubuisson JB. Treatment of adnexal torsion using operative laparoscopy. Hum Reprod (Oxf) 1996; 11: 998–1103.

    Article  CAS  Google Scholar 

  46. McHutchinson LL, Koonings PP, Ballard CA, d’Ablaing G III. Preservation of ovarian tissue in adnexal torsion with fluorescein. Am J Obstet Gynecol 1993; 168: 1386–1388.

    Article  PubMed  CAS  Google Scholar 

  47. Goldstein SR, Subramanyam B, Snyder JR, Beller U, Raghavendra BN, Beckman EM. The postmenopausal cystic adnexal mass: the potential role of ultrasound in conservative management. Obstet Gynecol 1989; 73: 8–10.

    PubMed  CAS  Google Scholar 

  48. Bailey CL, Ueland FR, Land GL, et al. The malignant potential of small cystic ovarian tumors in women over 50 years of age. Gynecol Oncol 1998; 69: 3–7.

    Article  PubMed  CAS  Google Scholar 

  49. Yuen PM, Yu KM, Yip SK, Lau WC, Rogers MS, Chang A. A randomized prospective study of laparoscopy and laparotomy in the management of benign ovarian masses. Am J Obstet Gynecol 1997; 177: 109–114.

    Article  PubMed  CAS  Google Scholar 

  50. Montz FJ, Schlareth JB, Morrow CP. The natural history of theca lutein cysts. Obstet Gynecol 1988; 72: 247–251.

    PubMed  CAS  Google Scholar 

  51. Marcoux S, Maheux R, Berube S. Laparoscopie surgery in infertile women with minimal or mild endometriosis: Canadian Collaborative Group on Endometriosis. N Engl J Med 1997; 337: 217–222.

    Article  PubMed  CAS  Google Scholar 

  52. Sandenbergh HA, Woodruff JD. Histogenesis of pseudomyxoma peritonei. Review of 9 cases. Obstet Gynecol 1977; 49: 339–345.

    PubMed  CAS  Google Scholar 

  53. Surveillance, Epidemiology and End Results (SEER) Cancer Statistics Review 1973–1995. Bethesda: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, Cancer Statistics Branch, May 1998.

    Google Scholar 

  54. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000; 50: 7–33.

    Article  PubMed  CAS  Google Scholar 

  55. Einhorn N, Sjovall K, Knapp RC, et al. Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer. Obstet Gynecol 1992; 80: 14–18.

    PubMed  CAS  Google Scholar 

  56. Colombo N, Chiari S, Maggioni A, Bocciolone L, Torri V, Mangioni C. Controversial issues in the management of early epithclian ovarian cancer: conservative surgery and role of adjuvant therapy. Gynecol Oncol 1994; 55: S47 - S51.

    Article  PubMed  CAS  Google Scholar 

  57. Griffiths CT. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr 1975; 42: 101–104.

    PubMed  CAS  Google Scholar 

  58. Hoskins WJ, McGuire WP, Brady MF, et al. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 1994; 170: 974–979.

    Article  PubMed  CAS  Google Scholar 

  59. van der Burg ME, van Lent M, Buyse M, et al. The effect of de-bulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecologic Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med 1995; 332: 629–634.

    Article  PubMed  Google Scholar 

  60. Redman CW, Warwick J, Luesley DM, Varma R, Lawton FG, Blackledge GR. Intervention debulking surgery in advanced epithelial ovarian cancer. Br J Obstet Gynaecol 1994; 101: 142–146.

    Article  PubMed  CAS  Google Scholar 

  61. NIH Consensus Development Panel on Ovarian Cancer. Ovarian cancer: screening, treatment, and follow-up. JAMA 1995; 273: 491–497.

    Article  Google Scholar 

  62. McGuire WP, Hoskins WJ, Brady MF, et al. Cyclophosphamide and cisplatin compared with paclitaxcl and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996; 334: 1–6.

    Article  PubMed  CAS  Google Scholar 

  63. Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patients. Cancer (Phila) 1985; 56: 403–412.

    Article  CAS  Google Scholar 

  64. Ferenczy A, Gelfand M. The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia. Am J Ob-stet Gynecol 1989; 160: 126–131.

    Article  CAS  Google Scholar 

  65. Maggino T, Romagnolo C, Landoni F, Sartori E, Zola P, Gadducci A. An analysis of approaches to the management of endometrial cancer in North America: a CTF study. Gynecol On-col 1998; 68: 274–279.

    CAS  Google Scholar 

  66. Peters WA III, Anderson WA, Thornton WN Jr, Morley GW. The selective use of vaginal hysterectomy in the management of adcnocarcinoma of the endometrium. Am J Obstet Gynecol 1983; 146: 285–289.

    PubMed  Google Scholar 

  67. Greer BE, Cain JM, Figge DC, Shy KK, Tamimi HK. Supraumbilical upper abdominal midline incision for pelvic surgery in the morbidly obese patient. Obstet Gynecol 1990; 76: 47l - 473.

    Google Scholar 

  68. Goff BA, Rice LW. Assessment of depth of myometrial invasion in endometrial adenocarcinoma. Gynecol Oncol 1990; 38: 46–48.

    Article  PubMed  CAS  Google Scholar 

  69. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group study. Cancer (Phila) 1987; 60: 2035–2041.

    Article  CAS  Google Scholar 

  70. Wilson TO, Podratz KC, Gaffey TA, Malkasian GD Jr, O’Brien PC, Naessens JM. Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma. Am J Obstet Gynecol 1990; 162: 418–423.

    Article  PubMed  CAS  Google Scholar 

  71. Sherman ME, Bitterman P, Rosenshein NB, Delgado G, Kurman RJ. Uterine serous carcinoma. A morphologically diverse neo-plasm with unifying clincopathologrc features. Am J Surg Pathol 1992; 16: 600–610.

    Article  PubMed  CAS  Google Scholar 

  72. Society of Gynecologic Oncologists. Clinical practice guidelines: uterine corpus-endometrial cancer. Oncology 1998; 12: 122–126.

    Google Scholar 

  73. Fanning J, Evans MC, Peters AJ, Samuel M, Harmon ER, Bates JS. Adjuvant radiotherapy for stage I, grade 2 endometrial adenocarcinoma and adenoacanthoma with limited myometrial invasion. Obstet Gynecol 1987; 70: 920–922.

    PubMed  CAS  Google Scholar 

  74. Roberts JA, Zaino R, Keys H. A phase III randomized study of surgery versus surgery plus adjunctive radiation therapy in intermediate risk endometrial adenocarcinoma. Proc Soc Gynecol Oncol 1998; 68: 258.

    Google Scholar 

  75. Thigpen JT, Blessing J, Holmsley HD, Lia S. Phase III trial of doxorubicin +/- cisplatin in advanced or recurrent endometrial carcinoma. Proc Am Soc Clin Oncol 1993; 12: 261.

    Google Scholar 

  76. Ball HG, Blessing JA, Lentz SS, Mutch DG. A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1996; 62: 278–281.

    Article  PubMed  CAS  Google Scholar 

  77. Fleming GF, Fowler JM, Waggoner SE, et al. Phase I trial of escalating doses of paclitaxel (TAX) combined with fixed doses of cisplatin (CIS) and doxorubicin (DOX) in patients with advanced gynecologic malignancies: a Gynecologic Oncology Group ( GOG) trial. Proc Am Soc Clin Oncol 1998; 1393.

    Google Scholar 

  78. The World Health Organization. The World Health Report 1999: Making a Difference. Geneva, Switzerland: World Health Organization, 1999.

    Google Scholar 

  79. Mishell DR, Stenchever MA, Droegemueller W, Herbst AL. Comprehensive Gynecology, 3rd Ed. St. Louis: Mosby-Year Book, 1997.

    Google Scholar 

  80. National Cancer Institute Workshop. The 1988 Bethesda system for reporting cervical/vaginal cytological diagnoses. JAMA 1989; 262: 931–934.

    Article  Google Scholar 

  81. Benedet J, Odicono F, Maisonneuve P, et al. FIGO annual report on the results of treatment in gynaecological cancer: carcinoma of the cervix uteri. J Epidemiol Biostat 1998; 3: 5–34.

    Google Scholar 

  82. Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin On-col 1999; 17: 1339–1348.

    CAS  Google Scholar 

  83. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999; 340: 1137–1143.

    Article  PubMed  CAS  Google Scholar 

  84. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatinbased radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999; 340: 1144–1153.

    Article  PubMed  CAS  Google Scholar 

  85. Peters WA III, Liu PY, Barrett RJ, et al. Cisplatin and 5-fluorouricil plus radiation therapy are superior to radiation therapy as adjunctive in high-risk early-stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: report of a phase III intergroup study. Proc Soc Gynecol Oncol 1999.

    Google Scholar 

  86. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999; 340: 1154–1161.

    Article  PubMed  CAS  Google Scholar 

  87. Bachmann GA. Hysterectomy: a critical review. J Reprod Med 1990; 35:839–462.

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

Cohn, D.E., Rader, J.S. (2001). Gynecology. In: Norton, J.A., et al. Surgery. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57282-1_88

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-57282-1_88

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-63239-6

  • Online ISBN: 978-3-642-57282-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics